Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sikarin PCLBKK:SKR 84 PS Ratio is 2.74 as of Aug. 14, 2026, which is 1% below its 10-year median of 2.78. GuruFocus rates BKK:SKR with a GF Score™ of 84/100 and a GF Value™ of ฿9.13 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 656 Healthcare Providers & Services companies, Sikarin PCL ranks worse than 67.23% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Sikarin PCL's share price is ฿7.95.
Sikarin PCL's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ฿2.90. Hence, Sikarin PCL's PS Ratio for today is 2.74.
The historical rank and industry rank for Sikarin PCL's PS Ratio or its related term are showing as below:
BKK:SKR'
s PS Ratio Range Over the Past 10 Years
Min: 2.14 Med: 2.78 Max: 5.58
Current: 2.74
During the past 13 years, Sikarin PCL's highest PS Ratio was 5.58. The lowest was 2.14. And the median was 2.78.
BKK:SKR's PS Ratio is ranked worse than 67.23% of 656
companies
in the Healthcare Providers & Services industry
Industry Median: 1.56
vs BKK:SKR: 2.74
Sikarin PCL revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Sikarin PCL was -1.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 2.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 5.60% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 9.70% per year.
During the past 13 years, Sikarin PCL's highest 3-Year average Revenue per Share Growth Rate was 22.20% per year. The lowest was -2.40% per year. And the median was 8.40% per year.
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Sikarin PCL PS Ratio Related Terms
Sikarin PCL PS Ratio Historical Data
* Premium members only.
The historical data trend for Sikarin PCL's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Sikarin PCL's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sikarin PCL PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Sikarin PCL's PS Ratio distribution charts can be found below:
* The bar in red indicates where Sikarin PCL's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Sikarin PCL's Share Price of today is ฿7.95. Sikarin PCL's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿2.90.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Sikarin PCL (BKK:SKR) has a PS Ratio of 2.74 as of Aug. 14, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Sikarin PCL and its competitors. This is near median its historical median of 2.78. Over the past decade, Sikarin PCL's PS Ratio has ranged from 2.14 to 5.58. According to the industry distribution chart, Sikarin PCL ranks #441 out of 656 companies in the Healthcare Providers & Services industry, placing it in the top 67.2%.
Is Sikarin PCL's PS Ratio too high?
Sikarin PCL's current PS Ratio of 2.74 is near median its 10-year median of 2.78. Over the past 10 years, this metric has ranged from a low of 2.14 to a high of 5.58. The Healthcare Providers & Services industry median PS Ratio is 1.56. Sikarin PCL's value of 2.74 is 75.6% above this industry median. Based on the distribution chart, Sikarin PCL ranks #441 out of 656 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Sikarin PCL has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sikarin PCL's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Sikarin PCL ranks #441 out of 656 companies for PS Ratio. This places Sikarin PCL in the lower half of its industry. The industry median PS Ratio is 1.56. Sikarin PCL's value of 2.74 is 75.6% above this benchmark. Historically, Sikarin PCL's own PS Ratio has ranged from 2.14 to 5.58 over the past decade. While the company's 10-year median is 2.78 vs. the industry median of 1.56, Sikarin PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.56, based on 656 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sikarin PCL's current PS Ratio of 2.74 is 75.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Sikarin PCL and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sikarin PCL's current PS Ratio is 2.74, which is near median its own 10-year median of 2.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sikarin PCL stock overvalued right now?
Based on GuruFocus' analysis, Sikarin PCL (BKK:SKR) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿9.13, compared to a current price of ฿7.95 — trading 12.9% below its estimated fair value. The current PS Ratio is 2.74, which is near median its 10-year median of 2.78 and 75.6% above the Healthcare Providers & Services industry median of 1.56. Sikarin PCL's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Sikarin PCL (BKK:SKR), the current PS Ratio is 2.74 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sikarin PCL (BKK:SKR) Overvalued in 2026?
Based on GuruFocus' analysis, Sikarin PCL stock appears to be undervalued.
The current stock price of ฿7.95 is trading 12.9% below its estimated GF Value™ of ฿9.13.
GuruFocus considers Sikarin PCL to be Modestly Undervalued.
Key valuation signals for BKK:SKR:
PS Ratio: 2.74 (near median its 10-year median of 2.78)
GF Value™: ฿9.13 vs. price of ฿7.95 (12.9% below fair value)
Industry Position: 75.6% above the Healthcare Providers & Services median (#441 of 656)
No single metric tells the full story. See the BKK:SKR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SSikarin PCL provides general healthcare services and operates under the social security system. The Group has one main operating segment, which is providing healthcare services through private hospitals and hospitals affiliated with the social security system. The Group operates in a single geographical area, which is Thailand. Its services include medical centers, a pediatric center, a women's institute, a radiology center, a neurology center, a rehabilitation center, and an orthopedic center.
84GF Score
Get the complete analysis for BKK:SKR
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SKR has been successfully added to your 
